Characteristics for 1,611 Patients Receiving Sugammadex or Neostigmine as the Primary Neuromuscular Blocking Reversal Agent Following Laparoscopic Cholecystectomy
| Characteristic | Sugammadex, n=601 | Neostigmine, n=1,010 | Standardized Difference |
|---|---|---|---|
| Age, years, median [IQR] | 49 [35-62] | 47 [33-61] | –0.05 |
| Male | 151 (25.1) | 294 (26.7) | –0.07 |
| Weight, kg, median [IQR] | 86 [71-103] | 87 [74-102] | –0.02 |
| American Society of Anesthesiologists Physical Status Classification | –0.17 | ||
| I | 28 (4.7) | 62 (6.1) | |
| II | 332 (55.2) | 613 (60.7) | |
| III | 226 (37.6) | 321 (31.8) | |
| IV | 15 (2.5) | 14 (1.4) |
Notes: Data are presented as n (%) unless otherwise indicated. IQR=25%-75% interquartile range. Standardized differences were calculated by dividing the differences in means or proportions between the 2 groups by their pooled standard deviations. An absolute standardized difference of >0.1 indicates imbalance.27